1. Zhu J, Shi L, Du G, Li L, Liu M. Upregulated SET Promotes Cell Survival Through Activating Akt/NF-κB Signal in Colorectal Carcinoma. Cancer Manag Res. 2020;12:4735-4745. https://doi.org/10.2147/CMAR.S255930 (IF:2.703) 2. Deliang Yu#, Jing Zhao#, Yuhong Wang, JingHu, Qinchuan Zhao, Jibin Li*, Jianjun Zhu*. Upregulated histamine receptor H3 promotes tumor growth and metastasis in hepatocellular carcinoma. Oncology Reports, 2019, 41:3347-3353. DOI: 10.3892/or.2019.7119. (IF:3.417) 3. Jianjun Zhu, Mingpeng Jin, Jiaojiao Wang, et al. TNFα induces Ca2+ influx to accelerate extrinsic apoptosis in hepatocellular carcinoma cells, Journal of Experimental & Clinical Cancer Research, 2018, 37(1): https://doi.org/10.1186/s13046-018-0714-6. (IF 6.217) 4. Jianjun Zhu, Fang Yan, Jia Tao, et al. Cdc37 facilitates cell survival of colorectal carcinoma via activating the CDK4 signaling pathway. Cancer Science, 2018,109(3):656-665. (IF: 4.372) 5. Jianjun Zhu, Shishan Deng, Jie Duan, et al. FBXL20 acts as an invasion inducer and mediates E-cadherin in colorectal adenocarcinoma. Oncology Letter, 2014, 7(6):2185-2191. (IF:1.664) 6. Jianjun Zhu, Kai Li, Lei Dong, et al. Role of FBXL20 in human colorectal adenocarcinoma. Oncology Reports, 2012, 28(6): 2290-2298. (IF:2.297) 7. 朱剑军,石丽洪. 沉默 HRH3 减少伪足形成抑制结肠癌细胞迁移[J].中国生物化学与分子生物学报,2020,36(8):945-951. 8. 朱剑军,吴昊. 结肠癌中HRH3表达对细胞增殖的影响[J].临床与实验病理学杂志,2020,36(6):652-656. 9. 朱剑军,燕芳,陶佳,朱晓华,刘家有,邓世山. 沉默CDC37抑制结肠癌细胞Lovo和Ls174T侵袭转移[J],中国生物化学与分子生物学报,2017,33(1):58-65. 10. 朱剑军,朱晓华,黄平,蒋辉,邓世山. 泛素蛋白酶体系统在Wnt通路中的研究进展[J],川北医学院学报,2015,30(2):255-259. 11. 朱剑军,段劼,林雪梅,王小玲,朱晓华,谢兴国,邓世山. 靶向沉默EphA8基因对人结肠腺癌细胞凋亡及细胞周期的影响[J],川北医学院学报,2014,29(2):141-146. 12. 刘家有,熊东,王卓娜,荣欣欣,朱剑军*. Cdc37在结直肠腺癌中的表达及临床意义的研究[J],实用肿瘤杂志,2014,29(5):436-439. 13. 朱晓华,邓世山,谢兴国,许仕全,冉茂成,谢少利,朱剑军. 结直肠腺癌发病基因fbxl20和E-cadherin的相关性研究[J],实用肿瘤学杂志,2013,27(6):509-515. 14. 朱晓华,谢杰斌,邓世山,谢兴国,荣欣欣,燕芳,朱剑军*. 结直肠腺癌发病基因fbxl20和set的相关性研究[J],川北医学院学报,2013, 28(5):451-456. 15. 朱剑军,蒋琴,袁粒星,陈尧. 靶向FBXL20基因的siRNA片段的筛选及其验证[J],中国生物化学与分子生物学报,2011,27(3):237-243. |